| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.84B | 41.52B | 37.46B | 33.97B | 32.78B | 32.64B |
| Gross Profit | 23.56B | 22.61B | 19.88B | 17.70B | 16.07B | 15.34B |
| EBITDA | 7.78B | 7.50B | 7.40B | 6.26B | 5.02B | 5.42B |
| Net Income | 1.74B | 1.62B | 3.69B | 2.84B | 2.06B | 919.00M |
Balance Sheet | ||||||
| Total Assets | 40.06B | 41.00B | 33.18B | 30.84B | 28.91B | 30.06B |
| Cash, Cash Equivalents and Short-Term Investments | 7.50B | 11.37B | 8.61B | 7.39B | 6.11B | 4.92B |
| Total Debt | 16.91B | 15.54B | 11.63B | 11.10B | 11.13B | 13.88B |
| Total Liabilities | 24.14B | 24.18B | 18.79B | 17.90B | 17.66B | 21.41B |
| Stockholders Equity | 12.51B | 13.59B | 11.29B | 10.16B | 9.06B | 7.49B |
Cash Flow | ||||||
| Free Cash Flow | 5.60B | 5.16B | 5.46B | 4.22B | 3.42B | 3.99B |
| Operating Cash Flow | 5.67B | 5.25B | 5.64B | 4.34B | 3.55B | 4.32B |
| Investing Cash Flow | -2.88B | -2.68B | -1.94B | 738.00M | 1.18B | -1.48B |
| Financing Cash Flow | -951.00M | 237.00M | -2.49B | -3.81B | -3.53B | -4.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥849.39B | 14.50 | ― | 1.30% | 27.81% | 23.24% | |
77 Outperform | ¥24.43B | 20.79 | ― | 3.50% | 11.96% | 10.15% | |
72 Outperform | ¥31.09B | 10.82 | ― | 4.39% | 17.36% | 0.17% | |
72 Outperform | ¥103.66B | 18.63 | ― | 3.44% | 6.52% | 74.47% | |
71 Outperform | ¥23.32B | 8.30 | ― | 2.18% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥54.99B | 17.56 | ― | 2.96% | 11.21% | -55.71% |